Following a devastating fire which caused significant damage to the Paterson cancer research facility in 2017, building work on the new Paterson building at The Christie NHS Foundation Trust in Manchester has completed.

The building is part of the Manchester Cancer Research Centre – a highly successful partnership between three powerhouses of innovation, The Christie, Cancer Research UK and The University of Manchester – and will be one of the top cancer research centres in the world. 

Integrated Health Projects (IHP), the joint venture between VINCI Building and Sir Robert McAlpine and its supply chain partners, Arup, BDP and Imtech have realised a fantastic, state-of-the-art facility that will lead world-class transformational cancer research.

The building is set to become home to the largest concentration of scientists, doctors and nurses in Europe. 300 scientists and 400 clinicians and operational staff, practicing what is known as ‘team science’, will deliver clinical trials covering the full extent of the patient pathway, from prevention and novel treatments to living with and beyond cancer.

At more than 25,000 sq metres and ten storeys high, the building is more than twice the size of the previous facility, allowing experts to deliver discovery research and translate their findings into innovative clinical trials, at scale.

The building will be occupied by all three of the partners. It’ll be home to the Cancer Research UK Manchester Institute, as well as several other teams from The University of Manchester’s Division of Cancer Sciences. It will also be Manchester’s scientific headquarters for discovery science within the international Alliance for Early Cancer Detection.

A central component of the building will be the new Cancer Research UK Cancer Biomarker Centre. The centre’s focus will be on biomarkers to aid in early cancer detection and diagnosis, and enable personalised management of a patient’s cancer, to determine which therapy will bring the most benefit.

Roger Spencer, chief executive at The Christie, comments:

“The Christie has been at the forefront of cancer research for over 120 years. Standard treatments that were first trialled here have improved the outcomes for millions of cancer patients across the world. This new centre allows us to build on this legacy, so it’s exciting to see the vision become a reality.

“We want to give every patient who walks through our doors the best possible treatment and care. Having so many different specialists collaborating together under one roof will help us achieve our ambition to make the facility one of the top five cancer research centres in the world.”

IHP and VINCI Building’s Managing Director, John Roberts said:

“Ever since IHP were appointed to deliver the Paterson Building for The Christie NHS Foundation Trust, the whole team have been extremely proud to have played their part in delivering this new state of the art cancer research facility.

“Sadly, our friends, families and colleagues are all affected by cancer at some point and the opportunity to have contributed towards creating the environment that will be instrumental in helping deliver pioneering research and medicine as the largest concentration in Europe is something IHP have been honoured with.

“Bringing together the science community and acute hospital in this manner opens a collaborative environment that will help The Christie NHS Foundation Trust stay at the forefront of treatment and care for their patients, for many years to come”

Michelle Mitchell, chief executive of Cancer Research UK, comments:

“As the world’s largest charitable funder of cancer research, Cancer Research UK is at the forefront of the global fight against the disease, bringing together millions of people who share our determination to beat it.

“Co-locating the Cancer Research UK Manchester Institute with The Christie fulfils our strategy of delivering scientific breakthroughs which translate into treatments for patients. I’m delighted to see teams moving in and look forward to seeing our researchers find faster routes to new prevention measures, tests and treatments.”

Professor Dame Nancy Rothwell, president and vice-chancellor of The University of Manchester, comments:

“The new research building will be a fantastic opportunity to accelerate cancer research in Manchester, not just because it will provide state-of-the-art facilities, but because it will bring together a fantastic workforce comprised of scientists, clinicians and support staff, including trainees, early career researchers and world-renowned investigators. It will enable staff from The University’s Division of Cancer Sciences to work side-by-side with colleagues from the Cancer Research UK Manchester Institute and The Christie, generating new ideas, making new discoveries and devising next-generation therapies.

“Together with the Proton Beam Therapy Centre and the Oglesby Cancer Research Building, the new facility will be the latest piece of the cancer campus jigsaw, generating a vibrant, high-quality environment for our highly motivated research teams, all seeking to improve the lives of cancer patients, not just in Manchester but world-wide.”